FdaApplication
ANDA 208111
Identifiers
- fda_app_no: ANDA208111
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2021-02-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE | 0.137MG/SPRAY;0.05MG/SPRAY | SPRAY, METERED;NASAL |
1 product